Downloads provided by UsageCounts
This is Ed J. Griffen's presentation at the monthly [virtual] Antiviral Drug Discovery (AViDD) Open Science Forum on 16 November 2022. His talk centers around the ASAP center's SARS-CoV-2/MERS-CoV Mpro program. You can find a recording of his talk on the AViDD Open Science Forum Youtube page Ed J. Griffen is a part of the AI-driven Structure-enabled Antiviral Platform (ASAP) AViDD Center and is a Project 5: Lead Optimization lead.
Antiviral Drug Discovery, AViDD, Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, AI-driven Structure-enabled Antiviral Platform (ASAP) AViDD Center, AViDD Open Science Forum
Antiviral Drug Discovery, AViDD, Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, AI-driven Structure-enabled Antiviral Platform (ASAP) AViDD Center, AViDD Open Science Forum
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 6 | |
| downloads | 4 |

Views provided by UsageCounts
Downloads provided by UsageCounts